BYAM REBECCA (Chief Financial Officer) purchased 3.8% of their position (20K shares) of HCW BIOLOGICS INC. on the open market
Open‑market purchase worth $41.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/9/2023ACC: 0001209191-23-036040
Officer· Chief Financial Officer
Since Jul 2021
+20K
Net shares
Net buyer
$41.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$2.06
Trade value
$41.29K
% of position
3.8%
6/9/2023
523.95K→543.95K
Total
Net shares
+20K
Net value
$41.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2023 | P · Purchase | +20K | $2.06 | $41.29K | 3.8% | 523.95K | 543.95K |
| Total | +20K | $41.29K | ||||||
Derivative Transactions0
No derivative transactions reported